Combination of microwave endometrial ablation and postoperative dienogest administration is effective for treating symptomatic adenomyosis
Other
OA: closed
CC0
⤵ 8 in-corpus citations
AI-generated summary
This study evaluated the combination of microwave endometrial ablation and postoperative dienogest, finding it effectively reduced pain and anemia in women with symptomatic adenomyosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
AIM: Menorrhagia and dysmenorrhea are common symptoms. Uterine adenomyosis is one of the causes of menorrhagia and dysmenorrhea. These symptoms often decrease the quality of life in women. Microwave endometrial ablation (MEA) is a recently developed procedure that enables endometrial ablation. Dienogest has long been used to suppress endometrium development and reduce adenomyosis-related dysmenorrhea. However, some cases could be resistant to dienogest. In this study, we evaluated the efficacy of a combination of MEA and postoperative dienogest in reducing adenomyosis-related dysmenorrhea and menorrhagia.
METHODS: Ten patients with hormone treatment-resistant symptomatic adenomyosis underwent MEA and were administered oral dienogest after the procedure. The primary endpoints were reduction in pain recurrence and anemia. The secondary endpoint was a change in the adenomyosis lesion and its symptomatic recurrence.
RESULTS: Statistically significant improvements were seen in the visual analog scale score and hemoglobin levels in women post-treatment. The difference in myometrial thickness pre- and post-MEA was statistically significant. There were no cases of symptomatic recurrence.
CONCLUSION: The combination of MEA and postoperative dienogest is useful for treating uterine adenomyosis with menorrhagia and dysmenorrhea.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (22)
- Comparison of combined transcervical resection of the endometrium and levonorgestrel-containing intrauterine system treatment versus levonorgestrel-containing intrauterine system treatment alone in women with adenomyosis: a prospective clinical trial via openalex
- Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile via openalex
- Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging via openalex
- Efficacy of multiple microwave endometrial ablation technique for menorrhagia resulting from adenomyosis via openalex
- Evaluation of surgical options in menorrhagia via openalex
- Gonadotrophin-releasing hormone analogue or dienogest plus estradiol valerate to prevent pain recurrence after laparoscopic surgery for endometriosis: a multi-center randomized trial via openalex
- Insertion of mirena after endometrial resection in patients with adenomyosis via openalex
- Long-Term Administration of Dienogest Reduces Recurrence after Excision of Endometrioma via openalex
- Long-term outcomes of microwave endometrial ablation for treatment of patients with menorrhagia: A retrospective cohort study via openalex
- Microwave endometrial ablation at a frequency of 2.45 GHz for menorrhagia: analysis of treatment results at a single facility via openalex
- Microwave endometrial ablation: development, clinical trials and outcomes at three years via openalex
- Postoperative administration of dienogest for suppressing recurrence of disease and relieving pain in subjects with ovarian endometriomas via openalex
- Postoperative administration of dienogest plus estradiol valerate versus levonorgestrel-releasing intrauterine device for prevention of pain relapse and disease recurrence in endometriosis patients via openalex
- Study of dienogest for dysmenorrhea and pelvic pain associated with endometriosis via openalex
- Surgical management of deep infiltrating endometriosis of the rectum: pleading for a symptom-guided approach via openalex
- [Therapy of endometriosis with dienogest] via openalex
- Use of dienogest over 53 weeks for the treatment of endometriosis via openalex
- W2163315477 via openalex
- W2012912116 via openalex
- W2739010978 via openalex
- W1995538453 via openalex
- W6716348549 via openalex
Cited by (8)
- Risk factors and countermeasures for abnormal uterine bleeding during dienogest therapy for adenomyosis: a review 2025
- The use of dienogest in treatment of symptomatic adenomyosis: A systematic review and meta-analysis 2024
- Medical Treatment of Adenomyosis 2022
- Current and Prospective Treatment of Adenomyosis 2021
- Adenomyosis and Abnormal Uterine Bleeding 2021
- High-Intensity Focused Ultrasound Combined With Gonadotropin-Releasing Hormone Agonist or Levonorgestrel-Releasing Intrauterine System in Treating Dysmenorrhea of Severe Adenomyosis 2021
- Case of adenomyosis causing the activation of the coagulation system after a complete loss of endometrium following microwave endometrial ablation 2021
- Comparison of dienogest versus combined oral contraceptive pills in the treatment of women with adenomyosis: A randomized clinical trial 2021
Source provenance
- europepmc
- last seen: 2026-10-14T06:08:39.101224+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:22:34.444095+00:00
- unpaywall
- last seen: 2026-10-14T06:23:58.021457+00:00
License: CC0
· commercial use OK